Hutchison Medipharma Limited
Clinical trials sponsored by Hutchison Medipharma Limited, explained in plain language.
-
New combo shows promise for tough stomach cancer
Disease control CompletedThis study tested a new drug combination (fruquintinib plus paclitaxel) in 703 people with advanced stomach cancer that had gotten worse after initial treatment. The goal was to see if the combo helps people live longer and controls the cancer better than paclitaxel alone. The ap…
Phase: PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called HMPL-453 tartrate, alone or with chemotherapy or another drug, in 190 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and see if the drug could shrink tumors or slow thei…
Phase: PHASE1, PHASE2 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New drug shows promise for hard-to-treat stomach cancers with MET gene flaw
Disease control CompletedThis study tested a drug called savolitinib in 110 people with advanced stomach or esophagus-stomach junction cancer whose tumors have a specific gene change (MET amplification). The goal was to see if the drug could shrink tumors and how safe it was. Participants took the drug b…
Phase: PHASE2 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated May 26, 2026 08:34 UTC